Serum Institute to ship COVID-19 vaccines to Canada in less than a month: Adar Poonawalla

Published On 2021-02-16 07:50 GMT   |   Update On 2021-02-16 07:50 GMT

Bengaluru: India's Serum Institute will ship COVID-19 vaccines to Canada within a month, its chief executive said on Monday, in a sign a diplomatic row triggered by Canadian Prime Minister Justin Trudeau's comments on political protests in India was easing.Trudeau said the months-long protests by farmers on the outskirts of Delhi were concerning, drawing a rebuke from the Indian government...

Login or Register to read the full article

Bengaluru: India's Serum Institute will ship COVID-19 vaccines to Canada within a month, its chief executive said on Monday, in a sign a diplomatic row triggered by Canadian Prime Minister Justin Trudeau's comments on political protests in India was easing.

Trudeau said the months-long protests by farmers on the outskirts of Delhi were concerning, drawing a rebuke from the Indian government which said it was an internal matter.

Last week, however, Trudeau spoke to Indian counterpart Narendra Modi and they discussed the two countries' commitment to democracy.

Modi also said India would do its best to supply COVID-19 vaccines sought by Canada.

On Monday Adar Poonawalla, the chief executive of Serum Institute of India (SII) - the world's largest vaccine maker - reaffirmed that commitment.

"As we await regulatory approvals from Canada, I assure you, @SerumInstIndia will fly out #COVISHIELD to Canada in less than a month; I'm on it!" Poonawalla said in a Tweet, using the brand name under which Serum produces the shot developed by Oxford University and AstraZeneca Plc.

India's SII has emerged as a key vaccine supplier amid the pandemic. Canada, like many other countries, is relying on foreign supplies because it is unable to produce the vaccine locally.

Experts and officials say India has been trying to use its vaccine dominance to shore up diplomatic support.


Tags:    
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News